These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1690291)

  • 1. Molecular effects of dimethylanatoxin on the peripheral nicotinic acetylcholine receptor.
    Costa AC; Swanson KL; Aracava Y; Aronstam RS; Albuquerque EX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):507-16. PubMed ID: 1690291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels.
    Ramoa AS; Alkondon M; Aracava Y; Irons J; Lunt GG; Deshpande SS; Wonnacott S; Aronstam RS; Albuquerque EX
    J Pharmacol Exp Ther; 1990 Jul; 254(1):71-82. PubMed ID: 1694895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.
    Swanson KL; Allen CN; Aronstam RS; Rapoport H; Albuquerque EX
    Mol Pharmacol; 1986 Mar; 29(3):250-7. PubMed ID: 2419745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
    Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
    Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and blockade of the acetylcholine receptor-ion channel by the agonists (+)-anatoxin-a, the N-methyl derivative and the enantiomer.
    Kofuji P; Aracava Y; Swanson KL; Aronstam RS; Rapoport H; Albuquerque EX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):517-25. PubMed ID: 1690292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of nicotinic acetylcholine receptors of vertebrates and insects by philanthotoxin.
    Rozental R; Scoble GT; Albuquerque EX; Idriss M; Sherby S; Sattelle DB; Nakanishi K; Konno K; Eldefrawi AT; Eldefrawi ME
    J Pharmacol Exp Ther; 1989 Apr; 249(1):123-30. PubMed ID: 2468760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
    Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
    J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
    Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
    Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule.
    Shaker N; Eldefrawi AT; Aguayo LG; Warnick JE; Albuquerque EX; Eldefrawi ME
    J Pharmacol Exp Ther; 1982 Jan; 220(1):172-7. PubMed ID: 6273528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization.
    Souccar C; Varanda WA; Aronstam RS; Daly JW; Albuquerque EX
    Mol Pharmacol; 1984 May; 25(3):395-400. PubMed ID: 6328265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.
    Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX
    Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced release of acetylcholine from guinea pig ileum longitudinal muscle-myenteric plexus by anatoxin-a.
    Gordon RK; Gray RR; Reaves CB; Butler DL; Chiang PK
    J Pharmacol Exp Ther; 1992 Dec; 263(3):997-1002. PubMed ID: 1469655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methylanatoxinol isomers: derivatives of the agonist (+)-anatoxin-a block the nicotinic acetylcholine receptor ion channel.
    Swanson KL; Aracava Y; Sardina FJ; Rapoport H; Aronstam RS; Albuquerque EX
    Mol Pharmacol; 1989 Feb; 35(2):223-31. PubMed ID: 2465486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor.
    Sherby SM; Eldefrawi AT; Albuquerque EX; Eldefrawi ME
    Mol Pharmacol; 1985 Mar; 27(3):343-8. PubMed ID: 3974572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells.
    McKay DB; Aronstam RS; Schneider AS
    Mol Pharmacol; 1985 Jul; 28(1):10-6. PubMed ID: 2410767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
    Weiland GA; Durkin JA; Henley JM; Simasko SM
    Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine.
    Rozental R; Aracava Y; Scoble GT; Swanson KL; Wonnacott S; Albuquerque EX
    J Pharmacol Exp Ther; 1989 Nov; 251(2):395-404. PubMed ID: 2478693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.
    Spivak CE; Maleque MA; Oliveira AC; Masukawa LM; Tokuyama T; Daly JW; Albuquerque EX
    Mol Pharmacol; 1982 Mar; 21(2):351-61. PubMed ID: 6285171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical studies on the ionic channel of Torpedo acetylcholine receptor.
    Eldefrawi ME; Eldefrawi AT
    Adv Cytopharmacol; 1979; 3():213-23. PubMed ID: 382785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
    Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX
    Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.